CorVel Co. (NASDAQ:CRVL) Shares Bought by Argent Trust Co

Argent Trust Co grew its stake in CorVel Co. (NASDAQ:CRVL - Free Report) by 324.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,351 shares of the business services provider's stock after purchasing an additional 2,561 shares during the quarter. Argent Trust Co's holdings in CorVel were worth $373,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Bessemer Group Inc. grew its position in CorVel by 6,350.0% during the 4th quarter. Bessemer Group Inc. now owns 258 shares of the business services provider's stock valued at $29,000 after purchasing an additional 254 shares during the last quarter. Fifth Third Bancorp lifted its holdings in CorVel by 45.9% in the fourth quarter. Fifth Third Bancorp now owns 321 shares of the business services provider's stock valued at $36,000 after acquiring an additional 101 shares during the period. Jones Financial Companies Lllp purchased a new position in shares of CorVel in the fourth quarter worth approximately $37,000. US Bancorp DE grew its position in shares of CorVel by 225.4% during the 4th quarter. US Bancorp DE now owns 384 shares of the business services provider's stock valued at $43,000 after acquiring an additional 266 shares during the period. Finally, GAMMA Investing LLC increased its position in CorVel by 175.2% in the fourth quarter. GAMMA Investing LLC now owns 432 shares of the business services provider's stock worth $48,000 after buying an additional 275 shares in the last quarter. 51.36% of the stock is owned by institutional investors.

Analyst Ratings Changes

Separately, StockNews.com raised shares of CorVel from a "hold" rating to a "buy" rating in a research note on Friday.

Insider Transactions at CorVel

In related news, Director Alan Hoops sold 10,200 shares of the business's stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $116.39, for a total transaction of $1,187,178.00. Following the completion of the transaction, the director now owns 118,213 shares in the company, valued at $13,758,811.07. The trade was a 7.94 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Jeffrey J. Michael sold 16,523 shares of the firm's stock in a transaction on Wednesday, April 9th. The stock was sold at an average price of $116.99, for a total value of $1,933,025.77. Following the completion of the sale, the director now directly owns 551,787 shares of the company's stock, valued at $64,553,561.13. The trade was a 2.91 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 48,723 shares of company stock worth $5,757,140. Insiders own 47.57% of the company's stock.

CorVel Stock Down 1.7 %

CRVL stock traded down $2.03 during mid-day trading on Friday, hitting $115.09. The company had a trading volume of 121,327 shares, compared to its average volume of 114,083. CorVel Co. has a 12-month low of $76.20 and a 12-month high of $128.61. The company has a 50-day moving average price of $111.25 and a 200 day moving average price of $115.24. The company has a market capitalization of $5.91 billion, a price-to-earnings ratio of 67.70 and a beta of 0.94.

CorVel (NASDAQ:CRVL - Get Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The business services provider reported $0.46 earnings per share for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

CorVel Company Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.